Packer M (2018) Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction
These drugs are extremely effective for blood glucose control and weight management, which, combined with their relatively limited side effect profile, makes them very appealing for diabetes treatment the purpose for which they originally received FDA approval
de Rojas, I
At Avena Natural Health, GLP-1 and GIP/GLP-1 peptides are not offered as shortcuts, but as part of a thoughtful, patient-centered plan
And because retatrutide is not FDA-approved, there is no standardized dosing schedule, no prescription oversight, and no medical supervision
About 50-75%, up to 85% of people discontinue GLP-1s within 2 yearsoften due to cost, side effects, or preference